Asia Pacific Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others

Asia Pacific Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others)

The APAC malaria treatment market is expected to grow from US$ 235.63 million in 2022 to US$ 347.39 million by 2028. It is estimated to register a CAGR of 6.7% from 2022 to 2028.

Initiatives by Government and Private Sectors to Raise Awareness About Malaria is Fueling the APAC Malaria Treatment Market

Malaria awareness campaigns help enhance knowledge regarding the disease, improve behaviors promoting health, and promote intersectoral collaboration and social support. The WHO coordinates the Global Malaria Programme (GMP) as part of its efforts to control and eradicate malaria. The program is led by the Global Technical Strategy for Malaria 2016–2030 adopted by the World Health Assembly in May 2015, which was further restructured in 2021. The WHO observes 25 April as World Malaria Day every year to highlight the collective energy and commitment of the malaria communities in uniting around the common objective of freeing from malaria. In 2016, India introduced its first National Framework for Malaria Elimination, which will be valid from 2016 through 2030. In 2019, the Indian government raised funding by more than 25% for the National Vector Borne Disease Control Programme, launched in 2003. The country has also increased its contribution as a donor to the Global Fund to fight Malaria. Several governments are taking initiatives to create awareness and conduct research to develop new antimalarial drugs and vaccines. Private companies are also engaging in the fight against malaria and investing heavily in R&D activities. Governments in countries with a high malaria prevalence are deploying various strategies to eradicate malaria by improving access to treatment and helping communities in malaria-endemic countries deliver better healthcare. Several initiatives by governments and private companies to spread awareness about malaria and reinforce malaria eradication efforts are bolstering the APAC malaria treatment market growth.

APAC Malaria Treatment Market Overview

The APAC malaria treatment market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022. According to the World Health Organization (WHO) 2021 report, China is awarded a malaria-free certification. China has achieved a 99% drop in malaria cases from 30 million to 30,000 cases annually. This is achieved by providing a basic public health service package for its residents without charging fees. From these packages, all people in China have access to affordable services for the diagnosis and treatment of malaria, regardless of legal or financial status. Additionally, multi-sector collaboration in China also played a big part in achieving zero cases in China. For example, 13 ministries in China—health, education, finance, research and science, development, public security, the army, police, commerce, industry, information technology, customs, media, and tourism—joined forces to end malaria. Further, through the support from the Global Fund to fight AIDS, tuberculosis, and malaria, China had stepped up training, laboratory equipment, staffing, and mosquito control measures that were required to find, treat, and prevent malaria cases in China, which, in turn, boosted the growth of the APAC malaria treatment market in the country.

Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

APAC Malaria Treatment Market Segmentation

The APAC malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the APAC malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the APAC malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the APAC malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the APAC malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the APAC malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the APAC malaria treatment market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Our regional analysis states that China dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, VLP Therapeutics LLC, and Zydus Healthcare Ltd are among the leading companies operating in the APAC malaria treatment market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution